9n7gwue6rkctot6rgg5w abveris logo 171213

Abveris, Inc

Stoughton, Massachusetts, US

Abveris is a contract lab that uses genetically engineered in vivo systems for the discovery of antibodies in tight timelines. Our hybridoma discovery platform technology is anchored on an immunogenetically-optimized rodent system. We deliver antibodies to targets, and individual epitopes on those targets, that cannot be found in natural in vivo systems.

Creating Antibodies with Custom Specificities

The limiting factor in most in-vivo antibody discovery platforms is the diversity of the immune response of the host animal. Abveris uses a proprietary rodent that has been engineered to express a more diverse antibody repertoire than regular animals. This enables the discovery of antibodies with specificities that cannot be found in other in-vivo systems.

When well-designed screening methods are applied to the large panel of hybridomas discovered, optimal antibodies are delivered. A wide range of screening methods... Show more »

Abveris is a contract lab that uses genetically engineered in vivo systems for the discovery of antibodies in tight timelines. Our hybridoma discovery platform technology is anchored on an immunogenetically-optimized rodent system. We deliver antibodies to targets, and individual epitopes on those targets, that cannot be found in natural in vivo systems.

Creating Antibodies with Custom Specificities

The limiting factor in most in-vivo antibody discovery platforms is the diversity of the immune response of the host animal. Abveris uses a proprietary rodent that has been engineered to express a more diverse antibody repertoire than regular animals. This enables the discovery of antibodies with specificities that cannot be found in other in-vivo systems.

When well-designed screening methods are applied to the large panel of hybridomas discovered, optimal antibodies are delivered. A wide range of screening methods and assay development capabilities are available.

Our optimized system has allowed Abveris to accelerate the timeline for delivery of monoclonal hybridoma cell lines in only 60 days.

Abveris’s platform can deliver antibodies to targets and epitopes that cannot be found in natural immune systems.

« Show less

Abveris, Inc has not listed any services.

Ask A Question Find what you're looking for? If not, you can ask this lab a question:
Antibody Discovery
Price on request

Royalty/milestone free, rapid delivery and you can expect antibodies to novel epitopes.

Royalty/milestone free, rapid delivery and you can expect antibodies to novel epitopes.

« Show less
Anti-idiotype Antibody Production
Price on request

We guarantee success on anti-id projects! We routinely screen for neutralizing and non-neutralizing anti-idiotypic mAbs.

Delivery time is rapid, usually 60 days.

We guarantee success on anti-id projects! We routinely screen for neutralizing and non-neutralizing anti-idiotypic mAbs.

Delivery time is rapid, usually 60 days.

« Show less
Monoclonal Antibody (mAb) Production
Price on request

Panels of custom-screened mAbs delivered against a wide variety of target types. Difficult targets are welcome.

Panels of custom-screened mAbs delivered against a wide variety of target types. Difficult targets are welcome.

« Show less
Biochemistry & Molecular Biology
Price on request
Request a quote for more information about this service.
Therapeutic Monoclonal Antibody (mAb) Development
Price on request
Request a quote for more information about this service.
Antibody Services
Price on request
Request a quote for more information about this service.
Protein Services
Price on request
Request a quote for more information about this service.
2018-02-01 09:51:27 -0800

Net Promoter Score of 8 received for Monoclonal Antibody (mAb) Production.

Additional Ratings: satisfaction with deliverable: 8, satisfaction with timeliness: 8.

Be the first to endorse Abveris, Inc

Endorse this lab